微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 67.91% | -15.22% | 1.15% | 35/160 | 22.89% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 67.13% | -14.17% | 1.71% | 36/160 | 33.26% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 66% | -22.8% | -18.77% | 36/160 | 51.37% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 81.25% | -4.24% | 1.44% | 21/160 | 51.38% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 80.09% | -5.93% | 2.4% | 25/160 | 32.75% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 78.22% | -8.2% | -8.51% | 25/160 | 38.61% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 85.49% | -1.02% | 0.76% | 14/160 | 52.91% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 84.85% | -0.42% | -0.35% | 15/160 | 53.57% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 85.14% | -1.21% | -0.07% | 12/160 | 6.69% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 85.2% | 0.6% | -1.35% | 12/160 | 21.79% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 86.37% | 1.6% | 1.37% | 12/160 | 54.47% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 85.21% | -0.88% | -1.14% | 19/160 | 55.07% | 首药控股 | 99.93% | 行业排名> |
| 2021-09-30 | 86.18% | -0.08% | 1.76% | 14/160 | 47.01% | 艾力斯 | 99.41% | 行业排名> |
| 2021-06-30 | 84.69% | 4.05% | -0.37% | 15/160 | 47.45% | 艾力斯 | 98.7% | 行业排名> |
| 2021-03-31 | 85.01% | 3.6% | -1.11% | 14/160 | 54.21% | 艾力斯 | 99.4% | 行业排名> |
| 2020-12-31 | 85.97% | 1.97% | -0.34% | 13/160 | -143.08% | 首药控股 | 99.94% | 行业排名> |
| 2020-09-30 | 86.26% | 2% | 5.97% | 11/160 | 56.57% | 泽璟制药 | 99.96% | 行业排名> |
| 2020-06-30 | 81.39% | -1.86% | -0.81% | 16/160 | 54.32% | 微芯生物 | 95.14% | 行业排名> |
| 2020-03-31 | 82.06% | 2% | -2.67% | 15/160 | 55.5% | 多瑞医药 | 95.59% | 行业排名> |
| 2019-12-31 | 84.3% | 3.82% | 1.65% | 12/160 | -1204.25% | 微芯生物 | 95.81% | 行业排名> |
| 2019-06-30 | 82.93% | 2% | 2.13% | 14/160 | 55.36% | 微芯生物 | 96.09% | 行业排名> |
| 2018-12-31 | 81.2% | 2.67% | 2.67% | 20/160 | -205.91% | 微芯生物 | 96.11% | 行业排名> |
| 2017-12-31 | 79.09% | 0.48% | 0.48% | 17/160 | 52.58% | 微芯生物 | 95.5% | 行业排名> |
| 2016-12-31 | 78.71% | 2% | 2% | 12/160 | 48.44% | 微芯生物 | 96.27% | 行业排名> |